- Home
- RRX vs SNN Comparison
RRX vs SNN Comparison
Compare RRX & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRX | SNN |
|---|---|---|
| Founded | 1955 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 13.2B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RRX | SNN |
|---|---|---|
| Price | $210.70 | $30.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $210.70 | $36.25 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 05-06-2026 | 03-16-2026 |
| Dividend Yield | 0.69% | ★ 2.48% |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $3,257,100,000.00 | N/A |
| Revenue This Year | $4.20 | $8.58 |
| Revenue Next Year | $12.13 | $5.60 |
| P/E Ratio | $215.09 | ★ $64.97 |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $127.96 | $28.56 |
| 52 Week High | $247.80 | $38.79 |
Technical Indicators
Market Signals| Indicator | RRX | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 47.22 |
| Support Level | $198.19 | $29.14 |
| Resistance Level | $222.63 | $31.06 |
| Average True Range (ATR) | 10.29 | 0.56 |
| MACD | -1.22 | 0.03 |
| Stochastic Oscillator | 24.95 | 45.00 |
Price Performance
Historical ComparisonAbout RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.